Cargando…
Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction
Opioid-induced bowel dysfunction (OIBD) comprises gastrointestinal (GI) symptoms, including dry mouth, nausea, vomiting, gastric stasis, bloating, abdominal pain, and opioid-induced constipation, which significantly impair patients’ quality of life and may lead to undertreatment of pain. Traditional...
Autor principal: | Leppert, Wojciech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404965/ https://www.ncbi.nlm.nih.gov/pubmed/25931815 http://dx.doi.org/10.2147/DDDT.S32684 |
Ejemplares similares
-
Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden
por: Panchal, S J, et al.
Publicado: (2007) -
Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction
por: Poulsen, Jakob Lykke, et al.
Publicado: (2014) -
The impact of opioid analgesics on the gastrointestinal tract function and the current management possibilities
por: Leppert, Wojciech
Publicado: (2012) -
Pain Management in Patients with Cancer: Focus on Opioid Analgesics
por: Leppert, Wojciech
Publicado: (2011) -
Erratum to: Pain Management in Patients with Cancer: Focus on Opioid Analgesics
por: Leppert, Wojciech
Publicado: (2011)